These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17002223)

  • 1. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.
    Huang Y
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.
    Huang Y
    Curr Opin Lipidol; 2010 Aug; 21(4):337-45. PubMed ID: 20531185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
    Huang Y
    Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
    Huang Y
    Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
    Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
    Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
    Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
    J Neurosci Res; 1999 Oct; 58(2):301-7. PubMed ID: 10502286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody against the polymorphic site distinguishes apolipoprotein E4 from other isoforms.
    Nukina N; Uchida K; Sakamoto T; Ide K; Kanazawa I
    Biochem Biophys Res Commun; 1995 Nov; 216(2):467-72. PubMed ID: 7488135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1996; 57 Suppl 14():5-8. PubMed ID: 9024330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for Alzheimer's disease].
    Yanagisawa K
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
    Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T
    Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
    Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
    Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
    Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
    Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.
    Morikawa M; Fryer JD; Sullivan PM; Christopher EA; Wahrle SE; DeMattos RB; O'Dell MA; Fagan AM; Lashuel HA; Walz T; Asai K; Holtzman DM
    Neurobiol Dis; 2005; 19(1-2):66-76. PubMed ID: 15837562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.
    Xu PT; Li YJ; Qin XJ; Scherzer CR; Xu H; Schmechel DE; Hulette CM; Ervin J; Gullans SR; Haines J; Pericak-Vance MA; Gilbert JR
    Neurobiol Dis; 2006 Feb; 21(2):256-75. PubMed ID: 16198584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils.
    Hatters DM; Zhong N; Rutenber E; Weisgraber KH
    J Mol Biol; 2006 Sep; 361(5):932-44. PubMed ID: 16890957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade.
    Ophir G; Amariglio N; Jacob-Hirsch J; Elkon R; Rechavi G; Michaelson DM
    Neurobiol Dis; 2005 Dec; 20(3):709-18. PubMed ID: 15979312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects.
    Ikewaki K; Zech LA; Brewer HB; Rader DJ
    J Lab Clin Med; 2002 Nov; 140(5):369-74. PubMed ID: 12434139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.